Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fosaprepitant for CINV in Head & Neck Cancer
NCT00895245Phase 2Terminated
- Sponsor
- University of Washington
- Start
- Feb 2009
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fosaprepitant in chemotherapy-induced nausea and vomiting (CINV), sponsored by University of Washington. Started Feb 2009; status: terminated.
02
Drugs
fosaprepitant
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT00895245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00895245.